What were Sun Pharma Advanced Research Company Ltd's latest quarterly results?
Sun Pharma Advanced Research Company Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: 0.0%
- Revenue Growth YoY: -46.7%
- Operating Margin: -670.0%
Sun Pharma Advanced Research Company Ltd: Stock Analysis & Fundamentals
Updated this weekSun Pharma Advanced Research Company Ltd (Pharma - Others) — fundamental analysis, earnings data, and key metrics. This stock is not currently in the Nifty 500 momentum outperformers list.
What's Happening
📊Debt increased 55% YoY — leverage rising
Key Numbers
Current Price
₹121
Market Cap
3.9K Cr
Valuation
N/AFrequently Asked Questions: Sun Pharma Advanced Research Company Ltd
Based on publicly available financial data. This is educational research, not investment advice.
Is Sun Pharma Advanced Research Company Ltd a fundamentally strong company?
Sun Pharma Advanced Research Company Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): -279.0%
Is Sun Pharma Advanced Research Company Ltd debt free?
Sun Pharma Advanced Research Company Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹269 Cr
What is Sun Pharma Advanced Research Company Ltd's return on equity (ROE) and ROCE?
Sun Pharma Advanced Research Company Ltd's return ratios over recent years
- FY2024: ROCE -108.0%
- FY2025: ROCE -279.0%
Is Sun Pharma Advanced Research Company Ltd's cash flow positive?
Sun Pharma Advanced Research Company Ltd's operating cash flow is negative (FY2025).
- Cash from Operations (CFO): ₹-360 Cr
- Free Cash Flow (FCF): ₹-202 Cr
What is Sun Pharma Advanced Research Company Ltd's dividend yield?
Sun Pharma Advanced Research Company Ltd currently does not pay a significant dividend (yield 0.00%).
- Dividend Yield: 0.00%
- Current Price: ₹121
Who holds Sun Pharma Advanced Research Company Ltd shares — promoters, FII, DII?
Sun Pharma Advanced Research Company Ltd's shareholding pattern (Dec 2025)
- Promoters: 65.7%
- FII (Foreign): 2.0%
- DII (Domestic): 0.8%
- Public: 31.5%
Is promoter holding increasing or decreasing in Sun Pharma Advanced Research Company Ltd?
Sun Pharma Advanced Research Company Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 65.7% (Dec 2025)
- Previous Quarter: 65.7% (Sep 2025)
- Change: 0.00% (stable)
Is Sun Pharma Advanced Research Company Ltd a new momentum entry or an established outperformer?
Sun Pharma Advanced Research Company Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Sun Pharma Advanced Research Company Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Sun Pharma Advanced Research Company Ltd may be worth studying
- Currently showing mixed signals — monitor for clearer trend confirmation
What is the investment thesis for Sun Pharma Advanced Research Company Ltd?
Sun Pharma Advanced Research Company Ltd investment thesis summary:
What is the future outlook for Sun Pharma Advanced Research Company Ltd?
Sun Pharma Advanced Research Company Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.